Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2020
Equity [Abstract]  
Summary of Stock Options Activity

The activity for stock options under the Company’s stock plans for the nine months ended September 30, 2020 is as follows:  

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

average

 

 

Per share

 

 

 

 

 

 

 

 

 

average

 

 

contractual

 

 

average

 

 

 

 

 

 

 

Price per

 

exercise

 

 

terms

 

 

intrinsic

 

 

 

Options

 

 

share

 

price

 

 

(in years)

 

 

value

 

Outstanding as of December 31, 2019

 

 

980,884

 

 

$0.75-$83.30

 

$

35.24

 

 

 

2.84

 

 

$

34.07

 

Exercised

 

 

(9,324

)

 

1.17-44.19

 

 

20.00

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(6,779

)

 

44.19-56.72

 

 

48.23

 

 

 

 

 

 

 

 

 

Outstanding as of September 30, 2020

 

 

964,781

 

 

0.75-83.30

 

 

35.30

 

 

 

2.09

 

 

 

5.56

 

Vested and exercisable as of September 30, 2020

 

 

964,781

 

 

0.75-83.30

 

 

35.30

 

 

 

2.09

 

 

 

5.56

 

Vested and expected to vest as of September 30, 2020

 

 

964,781

 

 

$0.75-$83.30

 

$

35.30

 

 

 

2.09

 

 

$

5.56

 

Summary of Restricted Stock Activity

Stock Awards activity for the nine months ended September 30, 2020 is summarized below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

grant

 

 

 

 

 

 

 

Performance

 

 

 

 

 

 

date fair

 

 

 

 

 

 

 

and

 

 

 

 

 

 

value

 

Restricted stock units

 

Time-based

 

 

time-based

 

 

Total

 

 

per share

 

Unvested restricted stock units as of December 31, 2019

 

 

108,976

 

 

 

3,134

 

 

 

112,110

 

 

$

83.48

 

Granted

 

 

202,924

 

 

 

88,458

 

 

 

291,382

 

 

 

43.85

 

Vested

 

 

(42,040

)

 

 

 

 

 

(42,040

)

 

 

83.06

 

Forfeited/canceled

 

 

(18,858

)

 

 

(3,134

)

 

 

(21,992

)

 

 

76.90

 

Unvested restricted stock units as of September 30, 2020 (1)

 

 

251,002

 

 

 

88,458

 

 

 

339,460

 

 

$

50.52

 

Unvested and expected to vest restricted stock units outstanding as

   of September 30, 2020

 

 

 

 

 

 

 

 

 

 

251,623

 

 

$

51.24

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

grant

 

 

 

 

 

 

 

Performance

 

 

 

 

 

 

date fair

 

 

 

 

 

 

 

and

 

 

 

 

 

 

value

 

Restricted stock awards

 

Time-based

 

 

time-based

 

 

Total

 

 

per share

 

Unvested restricted stock awards outstanding as of December 31, 2019

 

 

71,070

 

 

 

62,628

 

 

 

133,698

 

 

$

95.74

 

Vested

 

 

(22,704

)

 

 

 

 

 

(22,704

)

 

 

89.76

 

Forfeited/canceled

 

 

 

 

 

(29,273

)

 

 

(29,273

)

 

 

110.27

 

Unvested restricted stock awards outstanding as of September 30, 2020 (1)

 

 

48,366

 

 

 

33,355

 

 

 

81,721

 

 

$

93.42

 

Unvested and expected to vest restricted stock awards outstanding as

   of September 30, 2020

 

 

 

 

 

 

 

 

 

 

50,193

 

 

$

86.23

 

 

(1)

Outstanding restricted stock units and restricted stock awards are based on the maximum payout of the targeted number of shares.  

Summary of Stock-based Compensation Expense

Stock-based compensation

Stock-based compensation expense recognized for the three and nine months ended September 30, 2020 and September 30, 2019, was as follows:

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock option plan awards

 

$

 

 

$

590

 

 

$

709

 

 

$

2,513

 

Restricted stock units and restricted stock awards

 

 

1,878

 

 

 

834

 

 

 

4,853

 

 

 

3,882

 

Employee stock purchase plan

 

 

172

 

 

 

141

 

 

 

549

 

 

 

535

 

Total stock-based compensation expense

 

$

2,050

 

 

$

1,565

 

 

$

6,111

 

 

$

6,930

 

For the three and nine months ended September 30, 2020 and September 30, 2019, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

 

 

 

Three months ended

 

 

Nine months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Cost of revenue

 

$

185

 

 

$

172

 

 

$

511

 

 

$

656

 

Research and development

 

 

233

 

 

 

221

 

 

 

726

 

 

 

825

 

Sales and marketing

 

 

516

 

 

 

263

 

 

 

1,587

 

 

 

1,289

 

General and administrative

 

 

1,116

 

 

 

909

 

 

 

3,287

 

 

 

4,160

 

Total stock-based compensation expense

 

$

2,050

 

 

$

1,565

 

 

$

6,111

 

 

$

6,930